A Single Dose Study to investigate the safety of ACH-0145228 in Healthy Volunteers.
Phase 1
Completed
- Conditions
- Complement-mediated diseases
- Registration Number
- ACTRN12617001521314
- Lead Sponsor
- Achillion Pharmaceuticals, Inc.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 28
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method